Economic Evaluation of Voriconazole for the Treatment of Candidemia in Canadian Adults
2008
Coleman Rotstein | Lael Cragin | Michel Laverdière | Gary Garber | Eric J Bow | Alissa Scalera | Craig Roberts | Sonja V Sorenson | the Canadian Expert Panel
BACKGROUND: Candidemia is a common cause of nosocomial bloodstream infection. When selecting therapeutic treatments for candidemia, cost-effectiveness is an important consideration. The present study assessed the cost-effectiveness of voriconazole for the treatment of candidemia.
Show more [+] Less [-]Bibliographic information
This bibliographic record has been provided by Directory of Open Access Journals